Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Mark Kronenfeld Net Worth & Insider Trades

Mark Kronenfeld - Director, Pacira Biosciences, Inc

As of June 16, 2023

What is Mark Kronenfeld's Net Worth?

The current estimated net worth of Pacira Biosciences, Inc's Director, Mark Kronenfeld, is estimated to be about $1.04M . Mark Kronenfeld owns about 17,897 units of Pacira Biosciences, Inc common stock. In the last 10 years at Pacira Biosciences, Inc, Mark Kronenfeld has sold an estimated value of $597.86K worth.

What is Mark Kronenfeld's Past Insider Trading?

Mark Kronenfeld's largest purchase order was 15,000 units , worth over $448.5K on June 12, 2023. Mark Kronenfeld's largest sale order was 15,000 units , worth over $555.6K on June 12, 2023. In total, Mark Kronenfeld has made about 18 transactions over 10 years of their time at Pacira Biosciences, Inc. Mark Kronenfeld usually trades in June, with the busiest year in 2018, 2017, 2016, 2013, 2014, 2023 and 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mark Kronenfeld

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Mark Kronenfeld's' Mailing Address?

  • Mailing address is C/o Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 100 Parsippany NJ 07054 NJ

What are Pacira Biosciences, Inc's Past Insider Trades?

Pacira Biosciences, Inc's most recent insider trade came on August 4, 2023 by Roy Winston who sold 509 units worth $17.75K . In the last 11 years, insiders at Pacira Biosciences, Inc have sold an estimated value of $411.43M and bought an estimated value of $121.4M worth of shares. Insider trading is most common in June, with the busiest year in 2013. The most active traders at the company are David Stack, CEO and Chairman,  Andreas Wicki, Director,  and Bullaro Lauren Riker, Senior Vice President .

Pacira BioSciences, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...